AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits
Authors: Lasker, BA Elie, CM Lott, TJ Espinel-Ingroff, A Gallagher, L Kuykendall, RJ Kellum, ME Pruitt, WR Warnock, DW Rimland, D Mcneil, MM Reiss, E
Citation: Ba. Lasker et al., Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits, MED MYCOL, 39(4), 2001, pp. 341-352
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B
Authors: McGinnis, MR Nordoff, N Li, RK Pasarell, L Warnock, DW
Citation: Mr. Mcginnis et al., Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B, MED MYCOL, 39(4), 2001, pp. 369-371
Counterpoint: Invasive aspergillosis and the environment - Rethinking our approach to prevention
Authors: Hajjeh, RA Warnock, DW
Citation: Ra. Hajjeh et Dw. Warnock, Counterpoint: Invasive aspergillosis and the environment - Rethinking our approach to prevention, CLIN INF D, 33(9), 2001, pp. 1549-1552
Trends in mortality due to invasive mycotic diseases in the United States,1980-1997
Authors: McNeil, MM Nash, SL Hajjeh, RA Phelan, MA Conn, LA Plikaytis, BD Warnock, DW
Citation: Mm. Mcneil et al., Trends in mortality due to invasive mycotic diseases in the United States,1980-1997, CLIN INF D, 33(5), 2001, pp. 641-647
Gastrointestinal basidiobolomycosis in Arizona: Clinical and epidemiological characteristics and review of the literature
Authors: Lyon, GM Smilack, JD Komatsu, KK Pasha, TM Leighton, JA Guarner, J Colby, TV Lindsley, MD Phelan, M Warnock, DW Hajjeh, RA
Citation: Gm. Lyon et al., Gastrointestinal basidiobolomycosis in Arizona: Clinical and epidemiological characteristics and review of the literature, CLIN INF D, 32(10), 2001, pp. 1448-1455
Antifungal susceptibility testing: Practical aspects and current challenges
Authors: Rex, JH Pfaller, MA Walsh, TJ Chaturvedi, V Espinel-Ingroff, A Ghannoum, MA Gosey, LL Odds, FC Rinaldi, MG Sheehan, DJ Warnock, DW
Citation: Jh. Rex et al., Antifungal susceptibility testing: Practical aspects and current challenges, CLIN MICROB, 14(4), 2001, pp. 643-658
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998
Authors: Brandt, ME Pfaller, MA Hajjeh, RA Hamill, RJ Pappas, PG Reingold, AL Rimland, D Warnock, DW
Citation: Me. Brandt et al., Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998, ANTIM AG CH, 45(11), 2001, pp. 3065-3069
Trends in mortality due to invasive mycotic diseases in the United States,1980-1997
Authors: McNeil, MM Nash, SL Hajjeh, RA Phelan, MA Conn, LA Plikaytis, BD Warnock, DW
Citation: Mm. Mcneil et al., Trends in mortality due to invasive mycotic diseases in the United States,1980-1997, AM J HU GEN, 69(3), 2001, pp. 641-NIL_7
In vitro antifungal susceptibility methods and clinical implications of antifungal resistance
Authors: Espinel-Ingroff, A Warnock, DW Vazquez, JA Arthington-Skaggs, BA
Citation: A. Espinel-ingroff et al., In vitro antifungal susceptibility methods and clinical implications of antifungal resistance, MED MYCOL, 38, 2000, pp. 293-304
Candida dubliniensis Fungemia: the first four cases in North America
Authors: Brandt, ME Harrison, LH Pass, M Sofair, AN Huie, S Li, RK Morrison, CJ Warnock, DW Hajjeh, RA
Citation: Me. Brandt et al., Candida dubliniensis Fungemia: the first four cases in North America, EM INFECT D, 6(1), 2000, pp. 46-49
Infection may not have been caused by Exophiala jeanselmei
Authors: Padhye, AA Warnock, DW
Citation: Aa. Padhye et Dw. Warnock, Infection may not have been caused by Exophiala jeanselmei, CLIN INF D, 31(3), 2000, pp. 845-846
Lack of correlation of in vitro amphotericin B susceptibility testing withoutcome in a murine model of Aspergillus infection
Authors: Johnson, EM Oakley, KL Radford, SA Moore, CB Warn, P Warnock, DW Denning, DW
Citation: Em. Johnson et al., Lack of correlation of in vitro amphotericin B susceptibility testing withoutcome in a murine model of Aspergillus infection, J ANTIMICRO, 45(1), 2000, pp. 85-93
Comparative evaluation of PASCO and National Committee for Clinical Laboratory Standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts
Authors: Arthington-Skaggs, BA Motley, M Warnock, DW Morrison, CJ
Citation: Ba. Arthington-skaggs et al., Comparative evaluation of PASCO and National Committee for Clinical Laboratory Standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts, J CLIN MICR, 38(6), 2000, pp. 2254-2260
Report of the first human case of lobomycosis in the United States
Authors: Burns, RA Roy, JS Woods, C Padhye, AA Warnock, DW
Citation: Ra. Burns et al., Report of the first human case of lobomycosis in the United States, J CLIN MICR, 38(3), 2000, pp. 1283-1285
Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit
Authors: James, MJ Lasker, BA McNeil, MM Shelton, M Warnock, DW Reiss, E
Citation: Mj. James et al., Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit, J CLIN MICR, 38(10), 2000, pp. 3612-3618
Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis
Authors: Arthington-Skaggs, BA Warnock, DW Morrison, CJ
Citation: Ba. Arthington-skaggs et al., Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis, ANTIM AG CH, 44(8), 2000, pp. 2081-2085
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis and Histoplasma capsulatum
Authors: Li, RK Ciblak, MA Nordoff, N Pasarell, L Warnock, DW McGinnis, MR
Citation: Rk. Li et al., In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis and Histoplasma capsulatum, ANTIM AG CH, 44(6), 2000, pp. 1734-1736
Aspergillus antigen testing in bone marrow transplant recipients
Authors: Williamson, ECM Oliver, DA Johnson, EM Foot, ABM Marks, DI Warnock, DW
Citation: Ecm. Williamson et al., Aspergillus antigen testing in bone marrow transplant recipients, J CLIN PATH, 53(5), 2000, pp. 362-366
Antifungal drug susceptibility testing and resistance in Aspergillus
Authors: Warnock, DW Arthington-Skaggs, BA Li, RK
Citation: Dw. Warnock et al., Antifungal drug susceptibility testing and resistance in Aspergillus, DRUG RESIST, 2(5), 1999, pp. 326-334
Bioassays for itraconazole blood levels: an interlaboratory collaborative study
Authors: Odds, FC Dupont, B Rinaldi, MG Stevens, DA Warnock, DW Woestenborghs, R
Citation: Fc. Odds et al., Bioassays for itraconazole blood levels: an interlaboratory collaborative study, J ANTIMICRO, 43(5), 1999, pp. 723-727
Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds
Authors: Szekely, A Johnson, EM Warnock, DW
Citation: A. Szekely et al., Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds, J CLIN MICR, 37(5), 1999, pp. 1480-1483
Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens
Authors: Campbell, CK Davey, KG Holmes, AD Szekely, A Warnock, DW
Citation: Ck. Campbell et al., Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens, J CLIN MICR, 37(3), 1999, pp. 821-823
In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens
Authors: Johnson, EM Szekely, A Warnock, DW
Citation: Em. Johnson et al., In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens, ANTIM AG CH, 43(5), 1999, pp. 1260-1263
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
Authors: Morgenstern, GR Prentice, AG Prentice, HG Ropner, JE Schey, SA Warnock, DW
Citation: Gr. Morgenstern et al., A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies, BR J HAEM, 105(4), 1999, pp. 901-911
Infections in adults undergoing unrelated donor bone marrow transplantation
Authors: Williamson, ECM Millar, MR Steward, CG Cornish, JM Foot, ABM Oakhill, A Pamphilon, DH Reeves, B Caul, EO Warnock, DW Marks, DI
Citation: Ecm. Williamson et al., Infections in adults undergoing unrelated donor bone marrow transplantation, BR J HAEM, 104(3), 1999, pp. 560-568
Risultati: 1-25 | 26-28